Claire Jackson > Slaughter and May > London, England > Lawyer Profile

Slaughter and May
ONE BUNHILL ROW
LONDON
EC1Y 8YY
England

Living Wage

Work Department

Corporate, Corporate and M&A, Equity Capital Markets, Private Acquisitions and Disposals, Public Takeovers and Mergers, Healthcare, Pharma and Life Sciences

Position

Partner; Claire has a broad corporate and corporate finance practice, advising on all forms of domestic and international M&A transactions, including public takeovers, private acquisitions and disposals, joint ventures, and equity financings. She has particular expertise in the pharmaceutical, life sciences and healthcare and insurance sectors.

Claire also has experience in shareholder activism and has advised a number of corporate clients on recent activist campaigns.

Career

Joined firm 2011. Partner since 2020.

Claire is an author of the United Kingdom chapter in The Shareholder Rights and Activism Review.

Lawyer Rankings

London > Industry focus > Life sciences and healthcare

(Next Generation Partners)

Claire Jackson   – Slaughter and May

The broad team at Slaughter and May handles a range of contentious and non-contentious issues, such as patent disputes, the commercialisation of patent portfolios, and mandates -relating to confidential information. Claire Jackson leads the team alongside Duncan Blaikie; Jackson has a great deal of expertise in corporate matters, often advising clients on demergers and joint ventures, while Blaikie primarily handles IP-related issues, including R&D, licensing and collaboration agreements.

London > Corporate and commercial > M&A: Upper Mid-Market And Premium Deals, £750m+

Operating across a host of sectors including TMT, healthcare, construction, oil & gas and insurance and with unrivalled experience advising listed companies on M&A as well as activism defence work,  Slaughter and May’s M&A team is  ‘absolutely first class on all matters’. With a growing roster of top name clients and with more than 70% of its mandates last year involving an  international element, the team is regularly called in to advise on blockbuster deals such as GSK’s demerger of Haleon. The practice is co-headed by public and private M&A partners Simon Nicholls , who is described as ‘outstanding’ and ‘exceptional’ for his complex work for clients such as GSK and Diageo, and Richard Smith, whose clients include Aviva, Equinix and The Walt Disney Company. Senior partner Steve Cooke offers particular experience in takeover bids and other stock exchange related work, while data privacy expert Rebecca Cousin handles public and private M&A, initial public listings, equity issues and joint ventures. Roland Turnill , who will replace Cooke as senior partner in 2024, co-heads the financial institutions group and has recently been involved in advising Vodafone on its merger with Three. ‘Top tier lawyer’ Paul Dickson and the ‘exceptional’ Sally Wokes are noted for their broad corporate practices, handling public takeovers, joint ventures and private M&A for domestic and international clients, listed and unlisted. Victoria MacDuff continues to have a wide-ranging corporate practice, advising on M&A deals and disposals, equity capital market transactions, reorganisations and joint ventures, with a particular focus on cyber security and the financial services and telecoms sector. Also recommended are: Claire Jackson, a life sciences, healthcare and insurance specialist; Andrew Jolly, who heads the sport team and, the ‘enthusiastic, energetic and relatable’ Robert Innes, who co-heads the tech transactions group. James Cook, Harry Hecht and Alexander Dustan are other key lawyers. Formerly senior figures within the team,  Andy Ryde and Jeff Twentyman have retired.